Seeking Alpha

It's likely to be a rough day for Idenix Pharmaceuticals (IDIX) after yesterday's announcement...

It's likely to be a rough day for Idenix Pharmaceuticals (IDIX) after yesterday's announcement regarding IDX20963. The shares are off 33% premarket and the downgrades are coming in fast. JPMorgan, JMP, and Deutsche Bank have all cut the shares and Baird has started the stock at Underperform.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs